Foreign Policy Blogs

Diary of a drug trial

The recent “victory” of GSK’s Avandia raises questions about protocols in clinical trials.  Curious about a trial participant’s perspective?  Ana Cantu at the American-Statesman recalls her own participation in a drug trial 5 years ago.

Exit mobile version